Anavex Life Sciences Corp (AVXL)

[La Flaca]

While I’m hopeful you’re correct, why do you think that the closer we get to readout at CTAD without a PR signals the unlikelihood that trial failed to meet endpoints? Or is your comment more influenced by the date the trial wrapped up (~ 4 months ago)? Look at CRTX - their PR was issued about 2 weeks before oral presentation at CTAD as a reference and example that they didn’t PR trial failure until 2 weeks before CTAD presentation?

Or is your comment that this, in combination with your other factors, signals that unlikelihood?